USANA Health Sciences (NYSE:USNA) Hits New 52-Week Low – Time to Sell?

USANA Health Sciences, Inc. (NYSE:USNA)’s share price reached a new 52-week low on Tuesday . The stock traded as low as $31.10 and last traded at $31.35, with a volume of 8614 shares. The stock had previously closed at $31.64.

Analyst Upgrades and Downgrades

USNA has been the topic of several recent research reports. DA Davidson upped their price objective on USANA Health Sciences from $35.00 to $38.00 and gave the company a “neutral” rating in a research report on Thursday, January 2nd. StockNews.com upgraded shares of USANA Health Sciences from a “buy” rating to a “strong-buy” rating in a report on Saturday, December 28th.

USANA Health Sciences Trading Down 1.2 %

The business has a 50 day simple moving average of $35.74 and a two-hundred day simple moving average of $37.89. The company has a market cap of $596.01 million, a PE ratio of 11.05, a price-to-earnings-growth ratio of 0.88 and a beta of 0.87.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the stock. Pacer Advisors Inc. grew its holdings in USANA Health Sciences by 16.5% in the third quarter. Pacer Advisors Inc. now owns 544,256 shares of the company’s stock valued at $20,638,000 after purchasing an additional 76,904 shares during the period. Pzena Investment Management LLC boosted its holdings in shares of USANA Health Sciences by 7.5% in the 3rd quarter. Pzena Investment Management LLC now owns 1,049,610 shares of the company’s stock valued at $39,801,000 after purchasing an additional 72,977 shares during the last quarter. Allspring Global Investments Holdings LLC grew its stake in shares of USANA Health Sciences by 14,068.2% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 38,821 shares of the company’s stock valued at $1,472,000 after buying an additional 38,547 shares during the period. Unison Advisors LLC acquired a new stake in shares of USANA Health Sciences during the 3rd quarter worth $683,000. Finally, Assenagon Asset Management S.A. raised its position in shares of USANA Health Sciences by 13.5% in the 3rd quarter. Assenagon Asset Management S.A. now owns 124,008 shares of the company’s stock worth $4,702,000 after buying an additional 14,756 shares during the period. Institutional investors and hedge funds own 54.25% of the company’s stock.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.